Cargando…

Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector

Recombinant adeno-associated viral (rAAV) vectors promote long-term gene transfer in many animal species. Significant effort has focused on the evaluation of rAAV delivery and the immune response in both murine and canine models of neuromuscular disease. However, canines provided for research purpos...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnett, Andrea L. H., Garikipati, Dilip, Wang, Zejing, Tapscott, Stephen, Chamberlain, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207220/
https://www.ncbi.nlm.nih.gov/pubmed/22065964
http://dx.doi.org/10.3389/fmicb.2011.00220
_version_ 1782215528806350848
author Arnett, Andrea L. H.
Garikipati, Dilip
Wang, Zejing
Tapscott, Stephen
Chamberlain, Jeffrey S.
author_facet Arnett, Andrea L. H.
Garikipati, Dilip
Wang, Zejing
Tapscott, Stephen
Chamberlain, Jeffrey S.
author_sort Arnett, Andrea L. H.
collection PubMed
description Recombinant adeno-associated viral (rAAV) vectors promote long-term gene transfer in many animal species. Significant effort has focused on the evaluation of rAAV delivery and the immune response in both murine and canine models of neuromuscular disease. However, canines provided for research purposes are routinely vaccinated against canine parvovirus (CPV). rAAV and CPV possess significant homology and are both parvoviruses. Thus, any immune response generated to CPV vaccination has the potential to cross-react with rAAV vectors. In this study, we investigated the immune response to rAAV6 delivery in a cohort of CPV-vaccinated canines and evaluated multiple vaccination regimens in a mouse model of CPV-vaccination. We show that CPV-vaccination stimulates production of neutralizing antibodies with minimal cross-reactivity to rAAV6. In addition, no significant differences were observed in the magnitude of the rAAV6-directed immune response between CPV-vaccinated animals and controls. Moreover, CPV-vaccination did not inhibit rAAV6-mediated transduction. We also evaluated the immune response to early rAAV6-vaccination in neonatal mice. The influence of maternal hormones and cytokines leads to a relatively permissive state in the neonate. We hypothesized that immaturity of the immune system would permit induction of tolerance to rAAV6 when delivered during the neonatal period. Mice were vaccinated with rAAV6 at 1 or 5 days of age, and subsequently challenged with rAAV6 exposure during adulthood via two sequential IM injections, 1 month apart. All vaccinated animals generated a significant neutralizing antibody response to rAAV6-vaccination that was enhanced following IM injection in adulthood. Taken together, these data demonstrate that the immune response raised against rAAV6 is distinct from that which is elicited by the standard parvoviral vaccines and is sufficient to prevent stable tolerization in neonatal mice.
format Online
Article
Text
id pubmed-3207220
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-32072202011-11-07 Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector Arnett, Andrea L. H. Garikipati, Dilip Wang, Zejing Tapscott, Stephen Chamberlain, Jeffrey S. Front Microbiol Microbiology Recombinant adeno-associated viral (rAAV) vectors promote long-term gene transfer in many animal species. Significant effort has focused on the evaluation of rAAV delivery and the immune response in both murine and canine models of neuromuscular disease. However, canines provided for research purposes are routinely vaccinated against canine parvovirus (CPV). rAAV and CPV possess significant homology and are both parvoviruses. Thus, any immune response generated to CPV vaccination has the potential to cross-react with rAAV vectors. In this study, we investigated the immune response to rAAV6 delivery in a cohort of CPV-vaccinated canines and evaluated multiple vaccination regimens in a mouse model of CPV-vaccination. We show that CPV-vaccination stimulates production of neutralizing antibodies with minimal cross-reactivity to rAAV6. In addition, no significant differences were observed in the magnitude of the rAAV6-directed immune response between CPV-vaccinated animals and controls. Moreover, CPV-vaccination did not inhibit rAAV6-mediated transduction. We also evaluated the immune response to early rAAV6-vaccination in neonatal mice. The influence of maternal hormones and cytokines leads to a relatively permissive state in the neonate. We hypothesized that immaturity of the immune system would permit induction of tolerance to rAAV6 when delivered during the neonatal period. Mice were vaccinated with rAAV6 at 1 or 5 days of age, and subsequently challenged with rAAV6 exposure during adulthood via two sequential IM injections, 1 month apart. All vaccinated animals generated a significant neutralizing antibody response to rAAV6-vaccination that was enhanced following IM injection in adulthood. Taken together, these data demonstrate that the immune response raised against rAAV6 is distinct from that which is elicited by the standard parvoviral vaccines and is sufficient to prevent stable tolerization in neonatal mice. Frontiers Research Foundation 2011-11-03 /pmc/articles/PMC3207220/ /pubmed/22065964 http://dx.doi.org/10.3389/fmicb.2011.00220 Text en Copyright © 2011 Arnett, Garikipati, Wang, Tapscott and Chamberlain. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.
spellingShingle Microbiology
Arnett, Andrea L. H.
Garikipati, Dilip
Wang, Zejing
Tapscott, Stephen
Chamberlain, Jeffrey S.
Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
title Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
title_full Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
title_fullStr Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
title_full_unstemmed Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
title_short Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
title_sort immune responses to raav6: the influence of canine parvovirus vaccination and neonatal administration of viral vector
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207220/
https://www.ncbi.nlm.nih.gov/pubmed/22065964
http://dx.doi.org/10.3389/fmicb.2011.00220
work_keys_str_mv AT arnettandrealh immuneresponsestoraav6theinfluenceofcanineparvovirusvaccinationandneonataladministrationofviralvector
AT garikipatidilip immuneresponsestoraav6theinfluenceofcanineparvovirusvaccinationandneonataladministrationofviralvector
AT wangzejing immuneresponsestoraav6theinfluenceofcanineparvovirusvaccinationandneonataladministrationofviralvector
AT tapscottstephen immuneresponsestoraav6theinfluenceofcanineparvovirusvaccinationandneonataladministrationofviralvector
AT chamberlainjeffreys immuneresponsestoraav6theinfluenceofcanineparvovirusvaccinationandneonataladministrationofviralvector